Release of platelet plasminogen activator inhibitor 1 in whole blood is increased in patients with type II diabetes.
about
Obesity is associated with impaired platelet-inhibitory effect of acetylsalicylic acid in nondiabetic subjectsTherapeutic potential of ACE inhibitors for the treatment of hypertension in Type 2 diabetes.Pathobiology and cell interactions of platelets in diabetes.Increased risk for cardiovascular outcomes and effect of cholesterol-lowering pravastatin therapy in patients with diabetes mellitus in the pravastatin anti-atherosclerosis trial in the elderly (PATE).Short and long-term outcome in diabetic patients with acute myocardial infarction in the invasive era.
P2860
Release of platelet plasminogen activator inhibitor 1 in whole blood is increased in patients with type II diabetes.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Release of platelet plasminoge ...... atients with type II diabetes.
@en
Release of platelet plasminoge ...... atients with type II diabetes.
@nl
type
label
Release of platelet plasminoge ...... atients with type II diabetes.
@en
Release of platelet plasminoge ...... atients with type II diabetes.
@nl
prefLabel
Release of platelet plasminoge ...... atients with type II diabetes.
@en
Release of platelet plasminoge ...... atients with type II diabetes.
@nl
P2093
P1433
P1476
Release of platelet plasminoge ...... atients with type II diabetes.
@en
P2093
Colwell JA
Lopes-Virella MF
P304
P356
10.2337/DIACARE.18.8.1150
P407
P577
1995-08-01T00:00:00Z